Effect of Marma Therapy on Migraine Relief

A CLINICO ANATOMICAL STUDY OF MARMA THERAPY ON SHANKHA,APANGA AND STHAPANI MARMA IN THE MANAGEMENT OF ARDHAVBHEDAKA (MIGRAINE) - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/07/113855

Enrollment

Registered

2026-07-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Mild to moderate cases of Ardhavbhedaka (Migraine) based on clinical assessment and MIDAS score.

Exclusion criteria

Exclusion criteria: Patients having severe systemic disorders such as uncontrolled hypertension, cardiac diseases, diabetes mellitus, tuberculosis, COPD, paralysis, malignant diseases, severe migraine conditions, sinusitis, meningitis, organic or injury-related headaches, chronic systemic diseases, psychiatric illnesses, pregnancy, lactation, and those taking other treatments for Ardhavbhedaka were excluded from the study

Design outcomes

Primary

Measure	Time frame
Marma Therapy will be effective to alleviate patient suffering from Ardhavbhedaka.Timepoint: 30 days	—

Secondary

Measure	Time frame
Marma Therapy will be providing a safe and effective treatment.Timepoint: 30 days.	—

Countries

India

Contacts

Public ContactProf Mahendra Sharma

PGIA Jodhpur

sepatmahi1310@gmail.com7615944045

Outcome results